申请人:Aster Susan D.
公开号:US20120041012A1
公开(公告)日:2012-02-16
Substituted spirocyclic amines of structural formula I are selective antagonists of the somatostatin sub-type receptor 5 (SSTR5) and are useful for the treatment, control or prevention of disorders responsive to antagonism of SSTR5, such as Type 2 diabetes, insulin resistance, lipid disorders, obesity, atherosclerosis, metabolic syndrome, depression, and anxiety.
结构式为I的取代螺环胺是生长抑素亚型受体5(SSTR5)的选择性拮抗剂,并且适用于治疗、控制或预防对SSTR5拮抗有反应的疾病,例如2型糖尿病、胰岛素抵抗、脂质代谢紊乱、肥胖症、动脉粥样硬化、代谢综合征、抑郁症和焦虑症。